AGL Inhibitors

AGL inhibitors predominantly target the intricate processes of glycogen metabolism. A representative class within this group is the alpha-glucosidase inhibitors, including Acarbose, Miglitol, and Voglibose. These chemicals delay glucose absorption by impeding carbohydrate digestion in the intestines. Reduced substrate availability can indirectly influence AGL's function, as it is responsible for the debranching process of glycogenolysis. A compound like Castanospermine, known to inhibit glucosidases, serves to highlight the depth of chemical influence on glycogen breakdown processes, modulating AGL's activity.

Other representatives, such as DNJ and Isofagomine, showcase the breadth of glucosidase inhibition within this category. The capability of these compounds to interfere with enzymes essential for various pathways, like glycosphingolipid biosynthesis, underscores the interconnected nature of these pathways with AGL's function. Moreover, inhibitors like Kifunensine and Swainsonine target mannosidase and protein glycosylation, further exemplifying the myriad of avenues through which glycogen metabolism, and consequently AGL's function, can be modulated.